Zydus Wellness Limited (BOM:531335)
506.75
+5.05 (1.01%)
At close: Jun 5, 2026
Zydus Wellness Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Zydus Wellness stock has a consensus rating of "Buy" and an average price target of ₹564.29. The average 1-year stock price forecast is 11.35% higher than the current stock price, while the lowest is ₹525.00 (+3.60%) and the highest is ₹600.00 (+18.40%).
Price Target: ₹564.29 (+11.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Zydus Wellness stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 8 | 8 |
Financial Forecast
Revenue This Year
53.51B
from 39.61B
Increased by 35.09%
Revenue Next Year
60.63B
from 53.51B
Increased by 13.31%
EPS This Year
13.41
from 7.30
Increased by 83.82%
EPS Next Year
17.49
from 13.41
Increased by 30.35%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 55.2B | ||
| Avg | 53.5B | ||
| Low | 51.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 39.4% | ||
| Avg | 35.1% | ||
| Low | 29.9% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 13.41 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 83.8% | ||
| Low | - |